Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 1-10 of 12

Page
per page
  1. MK-0752
    A4006 MK-0752
     1 Citation
    Summary: γ-secretase inhibitor
      ≥22.15 mg/mL
  2. BIBR 953 (Dabigatran, Pradaxa)
    A4077 BIBR 953 (Dabigatran, Pradaxa)
    Summary: Thrombin inhibitor,potent,reversible and direct
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  3. MG-132
    A2585 MG-132
     26 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, Cell permeable, reversible
      ≥23.78 mg/mL
  4. GM 6001
    A4050 GM 6001
     2 Citation
    Target: MMP
    Summary: Broad spectrum MMP inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.42 mg/mL
  5. Bivalirudin Trifluoroacetate
    A3244 Bivalirudin Trifluoroacetate
    Target: thrombin
    Summary: Reversible thrombin inhibitor
      ≥54.5 mg/mL
  6. Cathepsin S inhibitor
    A3284 Cathepsin S inhibitor
     1 Citation
    Target: Cathepsins
    Summary: Blocks MHCII antigen presentation
      ≥24.25 mg/mL
  7. Otamixaban
    A3690 Otamixaban
    Target: Factor Xa
    Summary: Direct factor Xa inhibitors,potent and selective
      ≥22.35 mg/mL
  8. Leupeptin, Microbial
    A2570 Leupeptin, Microbial
    Target: Cathepsins|Calpains|Trypsins
    Summary: Inhibitor of serine and cysteine proteases
      ≥24.7 mg/mL
  9. Semagacestat (LY450139)
    A8190 Semagacestat (LY450139)
    Summary: γ-secretase inhibitor
      insoluble in H2O; ≥18.05 mg/mL
  10. UAMC 00039 dihydrochloride
    B5780 UAMC 00039 dihydrochloride
    Target: Dipeptidyl-peptidase II
    Summary: dipeptidyl peptidase II (DPP-II) inhibitor
      ≥133.6 mg/mL

Items 1-10 of 12

Page
per page